FDA To Bolster Post-Approval Drug Oversight

Law360, New York (February 27, 2008, 12:00 AM EST) -- In the wake of a rash of recent drug recalls, the U.S. Food and Drug Administration reportedly is set to keep a closer eye on the use of medicines after they have reached the market, marking a shift from its traditional focus on pre-approval monitoring of new treatments.

The agency said it would start monitoring the use of medicines after they have been approved, as part of a larger safety initiative announced to staffers Tuesday, the Associated Press reported.

Under the new initiative, the FDA will...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.